Rocket Lab (NASDAQ: RKLB) has emerged as one of the most closely watched names in the commercial space industry heading into the final stretch of 2026.
Shares currently trade at $74.31, with a 24/7 Wall St. price target of $119.32, implying upside of roughly 68.87% over the next 12 months.
The recommendation is a buy, though analysts assign a medium confidence level of 50%, reflecting genuine execution risks that remain on the table.
RKLB has gained 16.66% over the past week and 40.45% over the past year, yet the stock remains well below its 52-week high of $151.
In Q2 2026, Rocket Lab posted $234 million in revenue, a 62% year-over-year increase that edged past the $230.94 million analyst consensus.
GAAP EPS came in at -$0.08, missing expectations by 4.30%, with $8.58 million in acquisition transaction costs weighing on the bottom line.
The company’s backlog jumped to $2.36 billion, a record that reflects deepening demand across government and commercial satellite markets.
The pending Iridium acquisition, alongside closed deals for Mynaric and Motiv, supports CEO Peter Beck’s stated vision of a “self-launching, tier-1 space power.”
Neutron, Rocket Lab’s medium-lift reusable rocket, is on track for a Q4 2026 inaugural launch, carrying an average selling price of $50 to $55 million per mission, with customers already booking full-price slots ahead of the first flight.
The addressable market has grown considerably, with the NSSL Lane 1 ceiling expanding from $5.6 billion to $17 billion, adding a significant tailwind to Rocket Lab’s launch business.
Recent contract wins have further strengthened the bull case, including a $397 million Flatellite award, an $816 million SDA Tracking Layer Tranche 3 contract, and a Golden Dome selection alongside Raytheon.
The bull scenario points to a 12-month price target of $155.70 if Neutron launches cleanly and the Iridium deal closes on schedule without major integration disruptions.
On the risk side, Rocket Lab still burns cash, guiding to a Q3 adjusted EBITDA loss of between $17 million and $23 million, with management raising $1.53 billion in ATM proceeds during the first half of 2026.
That fundraising diluted shareholders meaningfully, though bulls argue it built a balance sheet with roughly $2.4 billion in cash and securities to fund Neutron development and the Iridium platform.
A Neutron launch slip into 2027, Iridium integration missteps, or a failed test flight each represent credible downside scenarios that could push RKLB toward the bear-case target of $93.67.
For comparative context, Planet Labs (NYSE: PL) carries a $5.94 billion market cap and reported Q2 FY2027 revenue of $116.05 million growing at 58%, already posting positive non-GAAP EPS.
AST SpaceMobile (NASDAQ: ASTS) sits at an $18.63 billion market cap on just $31.52 million in Q2 2026 revenue, making Rocket Lab’s $2.36 billion backlog look considerably more substantive.
Intuitive Machines (NASDAQ: LUNR) is guiding to $900 million to $1 billion in 2026 revenue at a $2.53 billion market cap, offering a cheaper revenue multiple but lacking Rocket Lab’s launch vertical integration.
Long-range price projections from 24/7 Wall St. put RKLB at $126.41 in 2027, $174.38 in 2028, $227.22 in 2029, and $259.06 by 2030, assuming Neutron cadence and Iridium integration execute as planned.
With a beta of 2.612, RKLB is not a stock for the faint-hearted, but for investors who can stomach volatility, the Neutron debut could prove to be the catalyst that defines the company’s next chapter.
